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in Childhood and AdolescenceWith Inflammatory Burden
in Young People
Line Jee Hartmann Rasmussen, PhD; Terrie E. Moffitt, PhD; Louise Arseneault, PhD; Andrea Danese, MD, PhD;
Jesper Eugen-Olsen, PhD; Helen L. Fisher, PhD; HonaLee Harrington, BA; Renate Houts, PhD;
TimothyMatthews, PhD; Karen Sugden, PhD; BenjaminWilliams, BSc; Avshalom Caspi, PhD
IMPORTANCE Childhood stress exposure is associated with inflammation as measured by
C-reactive protein (CRP) and interleukin 6 (IL-6). However, findings are inconsistent and
effect sizes are small. The addition of soluble urokinase plasminogen activator receptor
(suPAR), a new biomarker of chronic inflammation, may improvemeasurement of
stress-related inflammatory burden.
OBJECTIVES To assess whether exposure to adverse experiences, stress, and violence is
associated with an increase in suPAR levels in young people and to test the hypothesis that
measuring suPAR in addition to CRP or IL-6 levels improves the assessment of the
inflammatory burden associated with early-life stress.
DESIGN, SETTING, AND PARTICIPANTS This cohort study included 1391 participants from a 1994
to 1995 birth cohort of twins from the nationally representative Environmental Risk
Longitudinal Twin Study in the United Kingdom. Participants were followed up until 18 years
of age (93% retention). Plasma samples were analyzed in July 2018, and statistical analysis
was performed fromOctober 1, 2018, to May 31, 2019.
EXPOSURES Adverse childhood experiences and childhood and adolescent experience of
stress and violence exposure.
MAIN OUTCOMES ANDMEASURES Plasma CRP, IL-6, and suPAR levels at 18 years of age.
RESULTS Among 1391 young people (mean [SD] age, 18.4 [0.36] years; 733 [52.7%] female),
those who had been exposed to stressful experiences had elevated suPAR levels by 18 years
of age after controlling for sex, bodymass index, and smoking: 0.03-ng/mL (95% CI,
0.01-0.05 ng/mL) increase in suPAR per each additional adverse childhood experience,
0.09-ng/mL (95% CI, 0.01-0.17 ng/mL) increase in suPAR per each additional severe
childhood experience of stress or violence, and 0.04-ng/mL (95% CI, −0.02 to 0.10 ng/mL)
increase in suPAR per each additional severe adolescent experience of stress or violence.
Individuals exposed tomultiple types of violence in both childhood and adolescence had
0.26-ng/mL (95% CI, 0.07-0.45 ng/mL) higher suPAR levels compared with children who did
not experience stress or violence. These stress-exposed young people were significantly
more likely to have elevated suPAR levels at 18 years of age even if they did not have elevated
CRP or IL-6 levels. Measuring suPAR in addition to CRP or IL-6 increased the association
between stress exposure and inflammatory burden. For example, after adjusting for CRP and
IL-6 levels, each additional adverse childhood experience was associated with a 0.05-mL
(95% CI, 0.03-0.07 ng/mL) increase in suPAR, each additional severe childhood experience
of stress or violence was associated with a 0.14-ng/mL (95% CI, 0.06-0.22 ng/mL) increase in
suPAR, and each additional severe adolescent experience of stress or violence was associated
with a 0.10-ng/mL (95% CI, 0.04-0.16 ng/mL) increase in suPAR.
CONCLUSIONS AND RELEVANCE The results suggest that adult inflammation is associated with
childhood exposure to stress. Adding information about suPAR to traditional biomarkers of
inflammationmay improve themeasurement of inflammatory burden associated with
exposure to stress and violence.
JAMA Pediatr. doi:10.1001/jamapediatrics.2019.3875
Published online November 4, 2019.
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E xposure to adverse experiences, stress, and violenceduringchildhoodandadolescence is associatedwithel-evated risk of physical and mental health problems
in adulthood,1 many of which have inflammatory origins.
Inflammation could constitute one of the underlyingmecha-
nisms responsible for the biological embedding of childhood
stress, indicating an association between exposure to early-
life adversity and adverse health outcomes in later life.2
C-reactiveprotein (CRP)and interleukin6 (IL-6) areamong
themost commonlymeasured biomarkers of inflammation.3
Different types of adverse experiences have been associated
with increasedCRPandIL-6 levels,4 includingmaltreatment,5,6
bullying,7-9 andsexual abuse.10However, findingsarenot con-
sistent; several studies reportnonsignificantassociations,4,11,12
andnotall associationswere foundaftercontrolling for thecon-
founding effects of smoking or obesity.10,13 TheDunedin Lon-
gitudinal Study14 recently found that exposure to childhood
risk factors, including adverse childhood experiences (ACEs),
was associated with higher levels of a novel biomarker of in-
flammation, soluble urokinase plasminogen activator recep-
tor (suPAR), inadults independentlyof smokingandbodymass
index (BMI).
suPAR is released to the bloodstream during proinflam-
matory conditionswhen themembrane-bound receptoruPAR
is cleaved from the surface of immunologically active cells.15
Plasma levels of suPAR are thought to reflect a person’s over-
all level of immune activity. Elevated suPAR levels are ob-
served inmanydiseases andpathologic conditions16-19 andare
associatedwith development and progression of disease, ad-
verse clinical outcomes, and mortality.20,21 High suPAR lev-
els are also positively correlatedwith CRP and IL-6 in general
and patient populations.14,22 Whereas CRP is an acute-phase
reactant andamarker of acute inflammation and infections,23
suPARappears to be less affectedby acute conditions.24Of in-
terest, suPAR is associated with disease and mortality inde-
pendent of CRP,21,25 the criterion standard marker of inflam-
mation, suggesting that combineduse of CRP and suPARmay
provide amore accurate estimate of inflammatory burden by
combining information about acute and chronic inflamma-
tion. Less is known about how suPAR compareswith IL-6. In-
terleukin 6 is an important cytokinewith proinflammatory or
anti-inflammatory properties depending on the specific im-
munologic context. In addition to the immunologic func-
tions of IL-6 in the acute-phase response, infections, inflam-
mation, and cancer, IL-6 exertsmultiple pleiotropic effects on
other cell types, thereby regulating metabolism, hematopoi-
esis, and the neuroendocrine system.26 Although suPAR has
been found to be associated with clinical outcomes indepen-
dent of IL-6,25 whether the combined use of IL-6 and suPAR
also provides additive information about inflammatory bur-
den is unknown.
This report extendsaprevious study14 by investigating the
associationbetweensuPARandexposuretoadverseexperiences,
stress, and violence during childhood and adolescence in the
population-representativeEnvironmentalRisk (E-Risk)Longi-
tudinal TwinStudy followedup to 18years of age.Weassessed
multipletypesofadverseexperiencesduringchildhoodandado-
lescenceandcumulativelyacrossthefirst2decadesof life inside
andoutsidethefamily, includingemotional,physical,andsexual
abuse;emotionalandphysicalneglect;peerbullying;cyberbul-
lying; andcrimeviolence. Inaddition toevaluating theseexpe-
riencesinrelationtosuPAR,wecomparedtheassociationofstress
and violence exposure with CRP and IL-6 levels and tested
whether adding suPAR to themeasurement of CRP or IL-6 lev-
elsprovidesadditional informationabout inflammationassoci-
atedwith stress and violence exposure.
Methods
Sample
Thiscohort study includedmembersof theE-RiskLongitudinal
TwinStudy,which tracks thedevelopmentofa 1994-1995birth
cohortof2232Britishchildren.26 Inbrief, theE-RiskLongitudi-
nalTwinStudysamplewasconstructedfrom1999to2000,when
1116 of 1203 eligible families (92.8%)with same-sex 5-year-old
twinsparticipated inhome-visitassessments.Thissamplecom-
prises1242(55.7%)monozygotic (MZ)and990(44.4%)dizygotic
(DZ) twins; sex was evenly distributed within zygosity (1140
[51.1%] female).Homevisitswereconductedwhenparticipants
wereaged5,7,10,12,and,mostrecently,18yearsofage(n = 2066
[92.6%]).At 18yearsof age, each twinwas interviewedbyadif-
ferent interviewer. The Joint SouthLondon andMaudsley and
the InstituteofPsychiatry researchethics committeeapproved
eachphaseof thestudy.Parentsgavewritten informedconsent,
andtwinsgaveoralassentbetween5and12yearsofageandthen
writteninformedconsentat18yearsofage.Plasmasampleswere
analyzedinJuly2018,andstatisticalanalysiswasperformedfrom
October 1, 2018, toMay 31, 2019.
The sample represents socioeconomic conditions in the
United Kingdom, as reflected in the families’ distribution on
a neighborhood-level socioeconomic index (ACORN [A Clas-
sification of Residential Neighborhoods], developed by CACI
Inc for commercial use): 25.6% of E-Risk Longitudinal Twin
Study families live in wealthy achiever neighborhoods com-
paredwith25.3%nationwide, 5.3%vs 11.6% live inurbanpros-
perity neighborhoods, 29.6%vs 26.9% live in comfortably off
Key Points
Question Is exposure to adverse experiences, stress, and violence
in childhood associated with an increase in blood levels of the
inflammatory biomarker soluble urokinase plasminogen activator
receptor in young people?
Findings In this cohort study of 1391 young people followed up
to 18 years of age in the United Kingdom, exposure to adverse
experiences, stress, and violence during childhood or adolescence
was associated with elevated levels of the soluble urokinase
plasminogen activator receptor at 18 years of age, even in children
who did not have elevated C-reactive protein or interleukin
6 levels.
Meaning The findings suggest that stress-related inflammation
begins at a relatively young age, and themeasurement of this
inflammatory burdenmay be improved by adding information
about soluble urokinase plasminogen activator receptor to
traditional biomarkers of inflammation.
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neighborhoods, 13.4%vs 13.9% live inmoderatemeansneigh-
borhoods, and 26.1% vs 20.7% live in hard-pressed neighbor-
hoods. The E-Risk Longitudinal Twin Study underrepresents
urbanprosperityneighborhoodsbecause suchhouseholds are
often childless.
Exposure to Adverse Experiences in Childhood
and Adolescence
Weassessed 4 forms of stressful experiences in childhood: (1)
ACEs, as introducedby theUSCenters forDiseaseControl and
Prevention ACEs Study1 and expanded by the Philadelphia
Urban ACE Survey27; (2) exposure to 6 types of severe child-
hoodexperiencesof stressorviolencebetweenbirth to 12years
of age; (3) exposure to 7 types of severe adolescent experi-
ences of stress or violence at 12 to 18 years of age; and (4) ex-
posure tocumulative stress andviolenceexperiences through-
out the life, as determined by applying latent class analysis
(LCA) to stress and violence experiences data in childhood
and adolescence. These measures have been reported
previously28-31 and are described in the Box and detailed in
eMethods 1 to 4 in the Supplement.
Inflammatory Biomarkers
Venous blood was collected from 1700 of the 2066 partici-
pants (82.3%)withEDTA tubes. Tubeswere spunat 2500g for
10minutesandplasmasamplesobtained.Sampleswerestored
at −80°C. Plasma samples were available for 1448 partici-
pants. PlasmaCRP (high-sensitivityCRP)wasmeasuredusing
enzyme-linked immunosorbent assay (ELISA) (Quantikine
ELISA Kit DCRP00, R&D Systems) following themanufactur-
er’sprotocol.Thecoefficientofvariationwas5.6%.PlasmaIL-6
levels were measured using ELISA (Quantikine HS ELISA Kit
HS600C, R&D Systems) following the manufacturer’s proto-
col. The coefficient of variationwas 12.6%. Plasma suPAR lev-
elswereanalyzedusingELISA (suPARnosticAUTOFlexELISA,
ViroGatesA/S) following themanufacturer’s protocol. The co-
efficient of variation was 6%.
Other Variables AssociatedWith Inflammation
Whenparticipantswere 18years of age,we recordedBMI ( cal-
culated as weight in kilograms divided by height in meters
squared), body temperature, current daily smoking, current
illness and injury (eTable 1 in theSupplement), anduseof anti-
inflammatory medication (corticosteroids) within the past 2
weeks. Children exposed to ACEs or stress and violence may
also be exposed to unsanitary homes, which could be associ-
atedwith elevated suPAR levels and potentially confound as-
sociations betweenACEs or stress and violence exposure and
suPAR level. The cleanliness of thehomeswas assessedwhen
children were 12 years by home visitors answering the ques-
tion, “Are visible rooms of the house clean?” (no, somewhat,
or yes).
Childhoodsocioeconomicstatus (SES)wasdefinedthrough
astandardizedcompositeofparental income,educational level,
and occupation. The 3 SES indicators were highly correlated
(r = 0.57-0.67) and loadedonto 1 latent factor. Thepopulation-
wide distribution of the resulting factorwas divided in tertiles
for analyses.35
Box. Description of StudyMeasures
ACEs
Twenty ACEs weremeasured during childhood and adolescence
up to 17 years of age: 10 conventional ACEs, corresponding to the
10 subcategories of childhood adversities introduced by the CDC
Adverse Childhood Experiences Study,1 and 10 expanded ACEs,
identified from the results from the Philadelphia Urban ACE Sur-
vey and routine activity theory, as previously described.28 The 10
conventional ACEs included physical abuse, sexual abuse, emo-
tional abuse, physical neglect, emotional neglect, domestic vio-
lence exposure, household substance abuse, family history of
mental illness, loss of a parent (parental death, separation, or di-
vorce), and parental antisocial behavior. The 10 expanded ACEs
included experiencing bullying, living in foster care, low childhood
socioeconomic status, peer substance use, low parental monitor-
ing (as evaluated by parents), low parental monitoring (as evalu-
ated by children), participant-perceived unsafe neighborhood,
high neighbor crime violencemeasured via neighbor survey,
neighborhood rated as unsafe through systematic social observa-
tion, and high-crime neighborhoodmeasured through official po-
lice records. Measurement details are provided in eMethods 1 in
the Supplement. Among children in this study, 197 (14.2%) had no
ACEs, 238 (17.1%) had 1 ACE, 229 (16.5%) had 2 ACES, and 727
(52.3%) had 3 or more ACES.
Severe Childhood Experiences of Stress or Violence
Exposure to 6 types of severe childhood experiences of stress or
violence was assessed repeatedly when the children were 5, 7, 10,
and 12 years of age, including exposure to domestic intimate part-
ner violence between themother and her partner, frequent bully-
ing by peers, physical maltreatment by an adult, sexual abuse,
emotional abuse and neglect, and physical neglect. Exposures
were coded from 12-year dossiers for each child that comprised
information from home visit staff, mothers, children, family physi-
cians, and child protection interventions. Each exposure during
childhood was coded on a 3-point scale (0 indicating no exposure,
1 indicating probable or less severe exposure, and 2 indicating defi-
nite or severe exposure). Following the guidelines by Finkelhor
et al,32 we operationalized severe childhood experiences of stress
or violence as the total number of adverse event types experi-
enced by a child. All severe childhood experiences or stress or vio-
lence were summed. Measurement details are provided in
eMethods 2 in the Supplement. Among children in this study,
1004 (72.2%) had no severe childhood experiences of stress or
violence, 298 (21.4%) had 1 experience, 59 (4.2%) had 2 experi-
ences, and 30 (2.2%) had 3 or more experiences.
Severe Adolescent Experiences of Stress or Violence
Severe adolescent experiences of stress or violence between the
ages of 12 and 18 years were assessed at age 18 years of age when
the twins were interviewed using the JVQ-R2,33,34 adapted as a
clinical interview.29 The adapted JVQ-R2 comprised 45 questions
covering 7 different forms of adverse experience: crime violence,
peer or sibling violence, cyber bullying, sexual abuse, maltreat-
ment, family violence, and neglect. Like severe childhood experi-
ences of stress or violence experiences, each exposure during ado-
lescence was coded on a 3-point scale (0 indicating no exposure,
1 indicating probable or less severe exposure, and 2 indicating defi-
nite or severe exposure). Severe adolescent experiences of stress
or violence were derived by summing the number of severe ado-
lescent experiences of stress or violence. Measurement details are
provided in eMethods 3 in the Supplement. In this study, 887
(continued)
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Statistical Analysis
BothCRPand IL-6 levelswere log-transformedto improvenor-
mality of their distributions, as commonly done.36 Distribu-
tions of CRP, IL-6, and suPAR levels are shown in the eFigure
in the Supplement. Sex-adjusted regression coefficientswere
calculated to test associations between the inflammatory bio-
markers with clinical characteristics of the sample. The asso-
ciation betweenACEs or stress and violence exposure and in-
flammationwas testedusingordinary least squares regression,
with continuous measures of CRP, IL-6, and suPAR levels.
Modelswere adjusted for sex, BMI, and smoking. Analyses of
suPAR levelswere adjusted for cleanliness of thehome, child-
hood SES, CRP level, or IL-6 level. We report unstandardized
Bandstandardizedβcoefficients,with95%CIsadjustedtocon-
trol for the nonindependence of observations of twinswithin
families. Estimates and 95% CIs for log-transformed vari-
ables were back-transformed by exponentiating.
To analyze associations of ACEs or stress and violence ex-
posure with combined CRP (untransformed values) and
suPAR levels or combined IL-6 (untransformed values) and
suPAR levels, we created groups characterized by high or low
levels of CRP and suPAR or IL-6 and suPAR, as previously
described.14 For CRP, we used the established clinical cutoff
(3mg/L [to convert tonanomoles per liter,multiply by9.524])
to identify participants with high CRP levels; thus, high CRP
level indicates a CRP level greater than 3 mg/L (n = 287
[20.6%]). Clinical cutoffs for suPARand IL-6havenot yet been
established. To identify participants with high suPAR or high
IL-6 levels, we chose a cutoff for each that corresponded to a
similar percentage as high CRP level; thus, high suPAR level
indicates a suPAR level greater than 3.81 ng/mL (n = 286
[20.6%]), andhigh IL-6 level indicatesan IL-6 levelgreater than
1.48 pg/mL (n = 286 [20.6%]). We created 4 groups of indi-
viduals characterized by (1) low CRP and low suPAR levels
(n = 920 [66.1%]), (2) high CRP and low suPAR levels (n = 185
[13.3%]), (3) lowCRP and high suPAR levels (n = 184 [13.2%]),
and (4) highCRPandhigh suPAR levels (n = 102 [7.3%]). Simi-
larly, we created 4 groups of individuals characterized by (1)
low IL-6 and low suPAR levels (n = 916 [65.9%]), (2) high IL-6
and low suPAR levels (n = 189 [13.6%]), (3) low IL-6 and high
suPAR levels (n = 189 [13.6%]), and (4) high IL-6 and high
suPAR levels (n = 97 [7.0%]).
In addition, we performed an LCA that combined ln
(CRP), ln(IL-6), and suPAR to classify participants into groups
basedoneachparticipant’s levelsof the3biomarkers, account-
ing for clustering of twinswithin families. The LCA identified
3 inflammation groups of individuals (eTable 2 and eTable 3
in theSupplement): lowlevelsofall 3biomarkers, elevatedCRP
and IL-6 levels, and elevatedCRP, IL-6, and suPAR levels. The
association between stress and violence exposure and the in-
flammation groups was tested using multinomial logistic re-
gression, reporting odds ratios (ORs) with 95% CIs. Two-
sided P < .05 was a priori designated statistically significant.
Results
Of the 2066 children participating at 18 years of age, 1419
(68.7%) had complete data for childhood and adolescent ad-
verse experiences; CRP, IL-6, and suPARmeasurements at 18
years of age; and the covariates BMI and smoking. Partici-
pants with levels greater than 4 SDs above the means of CRP
(n = 18), IL-6 (n = 7),orsuPAR(n = 3) levelswereexcluded, leav-
ing a final sampleof 1391 (mean [SD] age, 18.4 [0.36] years; 733
[52.7%] female).Nosignificantdifferenceswere foundfor those
with complete data included in this article vs those without
in terms of mean SES (mean, 1.99 [95% CI, 1.95-2.04] vs 2.02
[95%CI, 1.97-2.08]; P = .47), ACEs (mean, 3.22 [95%CI, 3.08-
3.36] vs 3.04 [95%CI, 2.86-3.21];P = .17), severe childhoodex-
periences of stress or violence (mean, 0.36 [95% CI, 0.33-
0.40]vs0.34[95%CI,0.29-0.39];P = .49),or severeadolescent
experiences of stress or violence (mean, 0.60 [95% CI, 0.55-
0.65] vs 0.55 [95% CI, 0.49-0.62]; P = .34).
CorrelatesofCRP, IL-6,andsuPARaregiveninTable1.Com-
paredwithmaleparticipants, femaleparticipantshadhigher lev-
els of CRP (r = 0.14; 95% CI, 0.08-0.20; P < .001) and suPAR
(r = 0.23; 95% CI, 0.17-0.29; P < .001) but not IL-6 (r = 0.002;
95%CI,−0.06to0.06;P = .95).ParticipantswithhighBMIshad
higher levels of all 3 inflammatory biomarkers (CRP: r = 0.35;
95% CI, 0.30-0.40; P < .001; IL-6: r = 0.19; 95% CI, 0.13-0.24;
P < .001; andsuPAR: r = 0.29;95%CI,0.22-0.35;P < .001). To-
bacco smokingwas associatedwith elevated levels of IL-6 (r =
0.06;95%CI,0.005-0.12;P = .03) andsuPAR(r = 0.22;95%CI,
0.16-0.28;P < .001)butnotCRP(r = 0.04;95%CI,−0.02to0.09;
P = .20). Incontrast,acuteconditions,suchasbodytemperature
andcurrent illnessor injury (Table 1 andeTable 1 in theSupple-
ment),were associatedwith elevated levels of CRP (body tem-
perature: r = 0.06; 95%CI, 0.004-0.12;P = .04; current illness
or injury: r = 0.18;95%CI,0.12-0.23;P < .001)and IL-6 (current
illness or injury: r = 0.14; 95% CI, 0.08-0.20; P < .001) but
not suPAR (body temperature: r = 0.03; 95%CI, −0.03 to0.09;
P = .31; current illnessor injury: r = 0.02;95%CI,−0.03 to0.08;
Box. (continued)
adolescents (63.8%) had no severe adverse experiences, 275
(19.8%) had 1 experience, 131 (9.4%) had 2 experiences, and 98
(7.0%) had 3 or more experiences.
Cumulative Stress andViolence Experiences
Three groups of stress or violence experiences were identified
with latent class analysis combining the 6 childhood and the 7
adolescent measures of severe experiences of stress or violence,
as previously described.31 The latent class analysis classified par-
ticipants into groups based on the degree of each participant’s
exposure (none, moderate, or severe), and the analysis was per-
formed using only participants who experienced at least 1 form of
stress or violence experience. The 3 groups identified were (1) indi-
viduals who were exposed primarily to parental intimate partner
violence during childhood (n = 213 [15.3%]), (2) individuals who
weremainly bullied by peers and experienced street crime during
childhood and adolescence (n = 354 [25.4%]), and (3) individuals
who experiencedmultiple types of violence during childhood and
adolescence (n = 129 [9.3%]). Measurement details are provided
in eMethods 4 in the Supplement.
Abbreviations: ACEs, adverse childhood experiences; CDC, Centers for
Disease Control and Prevention; JVQ-R2, Juvenile Victimization
Questionnaire, second revision.
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P = .36).Useof anti-inflammatorymedication (corticosteroids)
in the past 2 weeks was not associatedwith any of the inflam-
matorybiomarkers(CRP:r = 0.01;95%CI,−0.04to0.06;P = .65:
IL-6: r = −0.04;95%CI,−0.15 to0.07;P = .46;suPAR: r = 0.008;
95%CI,−0.07 to0.08;P = .83).The3 inflammatorybiomarkers
(CRP, IL-6,andsuPAR)werepositively intercorrelated (r = 0.25–
0.39) (Table 1).
Association of Adverse Experiences
With Inflammatory Biomarker Levels
Childrenexposed tomoreACEshadhigher levelsof suPARand
IL-6 but not CRP at 18 years of age. Only the association with
suPAR remained after adjustment for sex, BMI, and smoking
(CRP:B = 1.00;95%CI,0.97-1.03;IL-6:B = 1.01;95%CI,1.00-1.03;
suPAR:B = 0.03;95%CI,0.01-0.05) (Table2). Ingeneral,adverse
experiencesweremoststronglyassociatedwithsuPARat18years
of age. Participantswhoexperiencedstress andviolenceexpo-
sureaschildrenhadhigher levelsof suPARandIL-6butnotCRP
evenaftercontrollingforsex,BMI,andsmoking(suPAR:B = 0.09,
95%CI,0.01-0.17; IL-6:B = 1.06;95%CI, 1.01-1.12;CRP:B = 1.04;
95%CI,0.92-1.17) (Table2).Participantswhoexperiencedstress
andviolenceexposureasadolescentshadhigher levelsofsuPAR
andCRPbut not IL-6 (suPAR: B = 0.11; 95%CI, 0.05-0.18; CRP:
B = 1.09,95%CI, 1.00-1.18; IL-6:B = 1.02;95%CI,0.99-1.06),but
noneof theseassociations remainedafteradjustment forcovar-
iates (Table 2). Participants exposed to cumulative adverse ex-
periencesacrosschildhoodandadolescencehadelevatedsuPAR
levels. In particular, levels of suPAR (but not CRP or IL-6)were
elevated among those exposed to domestic violence (suPAR:
B = 0.25, 95% CI, 0.10-0.40; CRP: B = 1.04; 95% CI, 0.83-1.29;
IL-6:B = 1.01;95%CI,0.91-1.13)andthosewhoexperiencedmul-
tiple types of violence in childhood and adolescence (suPAR:
B = 0.26; 95% CI, 0.07-0.45; CRP: B = 1.06; 95% CI, 0.81-1.38;
IL-6: B = 1.02; 95%CI, 0.88-1.18) even after controlling for sex,
BMI, and smoking (Table 2).
Correlations amongdifferent typesof adverseexperiences
(eg, physical abuse, street crime, and cyber bullying) and CRP,
IL-6, and suPAR levels are presented in eTable 4 in the Supple-
ment. suPARwas associatedwith various forms of adverse ex-
periences, suggesting that theelevation in suPAR levels among
Table 1. Sex-Adjusted Correlates of Plasma CRP, IL-6, and suPAR at 18 Years of Age in the E-Risk Longitudinal Twin Study
Variable Total
CRPa IL-6a suPAR
r (95% CI)b P Value r (95% CI)b P Value r (95% CI)b P Value
Correlates of
inflammation
Female, No./
total No. (%)
733/1391 (52.7) 0.14 (0.08 to 0.20) <.001 0.002 (−0.06 to 0.06) .95 0.23 (0.17 to 0.29) <.001
BMI, mean (SE) 22.9 (0.15) 0.35 (0.30 to 0.40) <.001 0.19 (0.13 to 0.24) <.001 0.29 (0.22 to 0.35) <.001
Daily smoking,
No./total No. (%)
315/1391 (22.6) 0.04 (−0.02 to 0.09) .20 0.06 (0.005 to 0.12) .03 0.22 (0.16 to 0.28) <.001
Body
temperature,
mean (SE), °C
36.3 (0.02) 0.06 (0.004 to 0.12) .04 0.06 (−0.01 to 0.12) .07 0.03 (−0.03 to 0.09) .31
Current illness or
injury, No./total
No. (%)c
323/1390 (23.2) 0.18 (0.12 to 0.23) <.001 0.14 (0.08 to 0.20) <.001 0.02 (−0.03 to 0.08) .36
Anti-inflammatory
medication use,
No./total No.
(%)d
17/1391 (1.2) 0.01 (−0.04 to 0.06) .65 −0.04 (−0.15 to 0.07) .46 0.008 (−0.07 to 0.08) .83
Cleanliness of
home, No./total
No. (%)
107/1342 (8.0)e −0.04 (−0.10 to 0.02) .22 −0.07 (−0.12 to −0.005) .03 −0.11 (−0.17 to −0.05) <.001
Socioeconomic
status, No./total
No. (%)
466/1391 (33.5)f −0.05 (−0.11 to 0.01) .09 −0.10 (−0.16 to −0.03) .002 −0.16 (−0.22 to −0.10) <.001
Inflammatory
biomarkers,
mean (SE)
CRP level, mg/La 2.34 (0.11) NA NA 0.39 (0.33 to 0.44) <.001 0.25 (0.20 to 0.31) <.001
IL-6 level,
pg/mLa
1.19 (0.03) 0.39 (0.33 to 0.44) <.001 NA NA 0.27 (0.21 to 0.33) <.001
suPAR level,
ng/mL
3.23 (0.03) 0.25 (0.20 to 0.31) <.001 0.27 (0.21 to 0.33) <.001 NA NA
Abbreviations: BMI, bodymass index (calculated as weight in kilograms divided
by height in meters squared); CRP, C-reactive protein; E-Risk, Environmental
Risk; IL-6, interleukin 6; NA, not applicable; suPAR, soluble urokinase
plasminogen activator receptor.
SI conversion factor: to convert CRP to nanomoles per liter, multiply by 9.524.
a Log-transformed (natural logarithm).
b Standardized estimated regression coefficients; all correlations were adjusted
for sex, and P values were adjusted for clustering within families.
c The current illness or injury index is a count of 16 conditions present on the
day of blood sample obtainment. Correlations with individual illnesses and
injuries are provided in eTable 1 in the Supplement.
dAny use of anti-inflammatory medication (corticosteroids) in the past 2 weeks.
e Number of homes reported to be unclean by home visitors when children
were 12 years of age. A total of 205 (15.3%) were reported as somewhat clean,
and 1030 (76.8%) were reported as clean.
f Number of families scored as low on the social class composite. A total of 469
(33.7%) were scored as middle social class, and 456 (32.8%) were scored as
high social class.
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youngpeoplewhounderwentadverseexperienceswasnotspe-
cific toanyparticular typeofadverseexperiencebutwas rather
a function of cumulative exposure.
Homevisitor ratings allowedus to investigatewhether liv-
ing in a nonhygienic homeduring childhood and adolescence
explained the association between adverse experiences and
inflammation. Cleanliness of the homewas negatively corre-
lated with levels of suPAR (r = −0.11; 95% CI, −0.17 to −0.05;
P < .001) and IL-6 (r = −0.07; 95%CI, −0.12 to−0.005;P = .03)
butnotCRP (r = −0.04;95%CI,−0.10 to0.02;P = .22) (Table 1).
When controlling for cleanliness of the home, all adverse
experience exposures remained associated with elevated
suPAR level at 18 years of age (eTable 5 in the Supplement).
Childhood SES was negatively correlated with levels of
suPAR (r = −0.16; 95% CI, −0.22 to −0.10; P < .001) and IL-6
(r = −0.10; 95% CI, −0.16 to −0.03; P = .002) but not CRP
(r = −0.05; 95%CI, −0.11 to0.01;P = .09) (Table 1).When con-
trolling for SES, all adverseexperienceexposures remainedas-
sociatedwith elevated suPAR level at 18 years of age (eTable 5
in the Supplement).
Importance of suPAR in Adverse Experience–Associated
Inflammation
Adverse experiences were associated with suPAR apart from
any association with CRP and IL-6 (eTable 5 in the Supple-
ment). Measuring suPAR in addition to CRP or IL-6 increased
theassociationbetweenstressexposureand inflammatorybur-
den. For example, after adjusting forCRPand IL-6 levels, each
additional adverse childhood experiencewas associatedwith
a0.05-mL (95%CI, 0.03-0.07ng/mL) increase in suPAR, each
additional severe childhood experience of stress or violence
was associatedwith a 0.14-ng/mL (95%CI, 0.06-0.22 ng/mL)
increase in suPAR, and each additional severe adolescent ex-
perience of stress or violence was associated with a 0.10-
ng/mL (95% CI, 0.04-0.16 ng/mL) increase in suPAR. Young
peoplewhowere exposed tomoreACEs, childhood stress and
violence exposure, adolescent stress and violence exposure,
and cumulative stress and violence exposure were signifi-
cantlymore likely to have elevated levels of both CRP and su-
PARat 18yearsofage (ACEs:OR, 1.41;95%CI, 1.16-1.71;P < .001;
childhoodstress andviolenceexposure:OR, 1.33; 95%CI, 1.12-
1.57; P = .001; adolescent stress and violence exposure: OR,
1.28; 95% CI, 1.05-1.56; P = .02; cumulative stress and vio-
lence exposure:OR, 2.51; 95%CI, 1.27-4.97;P = .008) (Figure,
A, and eTable 6 in the Supplement) as well as elevated levels
of IL-6 and suPAR at 18 years of age (ACEs: OR, 1.39; 95% CI,
1.13-1.71;P = .002; childhoodstressandviolenceexposure:OR,
1.34; 95% CI, 1.11-1.63; P = .003; adolescent stress and vio-
lence exposure: OR, 1.35; 95% CI, 1.12-1.64; P = .002; cumu-
lative stress and violence exposure: OR, 3.04; 95% CI, 1.61-
5.73; P < .001) (Figure, B, and eTable 6 in the Supplement).
However, adverse experiences were also prominent in the
groupofparticipantswith lowCRPandhigh suPAR (or low IL-6
andhighsuPAR) levels,whowouldinadvertentlyhavebeenmis-
classifiedashavinglowinflammationifsuPARlevelshadnotbeen
measured.Similarly,theLCArevealedthatyoungpeoplewhohad
elevatedsuPARlevelsat18yearsofageinadditiontoelevatedCRP
and IL-6 levels hadbeen exposed tomoreACEs and childhood,
adolescent,andcumulativestressandviolenceexperiencescom-
paredwith thosewith low levelsof all 3 inflammatorybiomark-
ersorwith thosewithmainlyhigh levelsofCRPandIL-6butnot
suPAR (Figure, C, and eTable 7 in the Supplement).
Discussion
In this2-decadeprospectivecohort study,wetested theuseful-
nessofanewbiomarker, suPAR, tounderstandthebiologicalas-
sociationwithstress in the firstpartof the lifecourse.First, chil-
drenexposed toadversities and tomultiple formsof stress and
violenceduringchildhoodandadolescencehadelevatedsuPAR
levels by the time they reached 18years of age. Theassociation
couldnotbeattributed toBMI, smoking,or living inunhygienic
homes during that period. Second, suPAR levels appear to add
informationaboutthehealthimplicationsofstressfulexperiences
inchildhoodbeyond themoreestablishedbiomarkersCRPand
IL-6.Weobserved thestrongestassociationsbetweenstressex-
posureand inflammationwhencombiningbiomarkers, andwe
alsofoundthatadverseexperienceswereprominentinthegroup
ofparticipantswith lowCRPor low IL-6 level,whowouldhave
inadvertently been assigned to the low inflammation group if
suPARlevelshadnotbeenassayed.These results replicate find-
ings from theDunedinLongitudinal Study,14which found that
exposure toACEswasassociatedwithelevated levelsof suPAR
atmidlife.Thus, suPARmaybeavaluableadjunct toestimating
inflammatory burden that may be associated with childhood
stress exposure.This conclusionwas supportedbyanLCAthat
revealed that young people with elevated inflammation could
beseparated into2categories: thosewithelevatedCRPandIL-6
levels and thosewith elevatedCRP, IL-6, and suPAR levels, the
latter of which had stronger associations with adverse experi-
ences.
Inflammation has been the target of investigation for re-
searchers seeking to understand the biological variables as-
sociatedwith stress. Much of this work has relied onmeasur-
ing CRP and IL-6 levels. Ameta-analysis4 revealed significant
associations between ACEs and levels of these 2 inflamma-
tory biomarkers. However, effectswere small, andmore than
half of the studies,manyofwhichwerewell powered, didnot
reveal positive associations.
Part of thedifficultymaybe that traditionalmarkers of in-
flammationmixhistorical andacute effects; for example, CRP
and IL-6 are involved in the acute-phase response. suPAR, the
soluble form of uPAR, has been put forward as a marker of
chronic inflammation. The expression and shedding of uPAR
are upregulated under inflammatory conditions and in re-
sponse to immunologic stimuli.37,38 Thus, the suPAR level is
elevated inmanydiseaseswithan inflammatorycomponent,21
whereas it is generally low, althoughstill detectable, inhealthy
individuals.39 Common risk factors for chronic disease, such
as smoking and morbid obesity, are linked to elevated
suPAR levels,40 andelevated suPAR levels are associatedwith
development and progression of disease and adverse out-
comes, includingmortality.20 In contrast tomanymarkers of
inflammation, which are labile and rapidly upregulated and
downregulated,41,42 suPARappears to bemore stable and less
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sensitive to acute influences43 anddoesnot fluctuatewith cir-
cadian rhythm.44 Of the 2 categories of elevated inflamma-
tion identified by the LCA in this study, the onewith elevated
suPAR in addition to CRP and IL-6 was more strongly associ-
atedwith stress and violence exposure during childhood and
adolescence than the one withmainly elevated CRP and IL-6
levels. This finding supports the conclusion that adding su-
PAR to CRP and IL-6 measurement may improve the assess-
mentof chronic inflammationassociatedwithearly-life stress.
Limitations
This study has limitations. First, plasma samples were only
available for 1448participants in the longitudinal study.How-
ever,nosignificant stress-exposuredifferenceswere foundbe-
tweenparticipantswhodidanddidnotprovidebloodsamples.
Second,we studied twins,whomaynot represent singletons.
However, the same pattern of associations between adverse
experiences and suPAR levels was found in the Dunedin
Longitudinal Studycohort of singletons.14 Third, although the
distributional properties of suPAR are appealing for research
purposes, the optimal threshold for its use as adiagnostic bio-
marker has not yet been determined. Fourth, the detected ef-
fect sizes were modest for suPAR, although this is to be ex-
pected inasampleofgenerallyhealthyyoungadults.Moreover,
afterweexaminedcumulativeadverseexperiences,effect sizes
increased, a finding thatunderscores the importanceof evalu-
ating multiple risk factor exposures rather than any single
exposure.45 Fifth,we collected inflammationdata for the first
timeonly inparticipants at 18 years of age, preventingus from
analyzing the associationof stress andviolence exposurewith
inflammation trajectories over time. Longitudinal studies of
suPAR are needed. In addition, randomized clinical trials
of interventions intended to reduce effects of violence expo-
sure should include inflammation biomarkers as outcome
measures.46Onestudy47 foundthat favorable lifestyle changes
were associatedwith reduced suPAR levels, suggesting suPAR
as anoutcomemeasure for studies of potential reversibility of
chronic inflammation associated with early-life risk expo-
sures. Sixth, we were able to identify risk factors associated
with elevated suPAR levels, but because of the observational
study design, we cannot rule out noncausal, alternative ex-
planations of the associations.
Conclusions
Inflammationhasbeensuggested to fill theblackbox that con-
nects childhood stress exposure to poor adult health, and it is
undervigorous investigation.48Theresultsof thepresentstudy
suggest that adult inflammation is associatedwith childhood
stress exposure,2 with inflammation beginning by the time
young people exposed to stress reach 18 years of age. Along
with a previous report,14 the present study suggests that add-
ing information about suPAR to traditional biomarkers of in-
flammation may improve the measurement of stress-related
inflammatory burden.
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